Marubi(SH:603983) Jin Rong Jie·2025-12-12 00:04Core Viewpoint - Guangdong Marubi Biotechnology Co., Ltd. has submitted an application for listing on the Hong Kong Stock Exchange, with Goldman Sachs and CITIC Securities as joint sponsors, highlighting its position as a leading Chinese beauty company focused on anti-aging solutions [1] Company Overview - Marubi Biotechnology specializes in providing anti-aging skincare solutions and has over 20 years of experience in the industry, driven by synthetic biology technology [1] - The company emphasizes research and development, particularly in core technologies such as recombinant collagen, to innovate skincare products with anti-wrinkle, firming, and repairing effects [1] Market Position - According to a report by Frost & Sullivan, Marubi is the third largest beauty company in China in the segment of recombinant collagen skincare products, based on retail sales projected for 2024 [1]